The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Akebia Therapeutics Inc (NASDAQ: AKBA) closed at $2.13 in the last session, up 4.41% from day before closing price of $2.04. In other words, the price has increased by $4.41 from its previous closing price. On the day, 8.64 million shares were traded. AKBA stock price reached its highest trading level at $2.14 during the session, while it also had its lowest trading level at $2.01.
Ratios:
We take a closer look at AKBA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.21 and its Current Ratio is at 1.41.
On August 28, 2023, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.75.
Piper Sandler Upgraded its Neutral to Overweight on May 31, 2023, whereas the target price for the stock was revised from $2 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Butler John P. sold 46,409 shares for $1.83 per share. The transaction valued at 84,928 led to the insider holds 2,557,921 shares of the business.
Burke Steven Keith sold 7,144 shares of AKBA for $13,074 on Mar 03 ’25. The SVP, Chief Medical Officer now owns 809,090 shares after completing the transaction at $1.83 per share. On Mar 03 ’25, another insider, Burke Steven Keith, who serves as the Officer of the company, bought 7,144 shares for $1.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKBA now has a Market Capitalization of 556422080 and an Enterprise Value of 640031168. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.47. Its current Enterprise Value per Revenue stands at 3.996 whereas that against EBITDA is -73.55.
Stock Price History:
The Beta on a monthly basis for AKBA is 0.84, which has changed by -0.036199093 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, AKBA has reached a high of $2.89, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 3.15%, while the 200-Day Moving Average is calculated to be 30.72%.
Shares Statistics:
According to the various share statistics, AKBA traded on average about 3.13M shares per day over the past 3-months and 8507150 shares per day over the past 10 days. A total of 236.23M shares are outstanding, with a floating share count of 226.53M. Insiders hold about 4.10% of the company’s shares, while institutions hold 26.51% stake in the company. Shares short for AKBA as of 1740700800 were 14879018 with a Short Ratio of 4.76, compared to 1738281600 on 14453171. Therefore, it implies a Short% of Shares Outstanding of 14879018 and a Short% of Float of 6.890000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
